Dose Kelofan Syrup Effective for Clinical Symptoms and Biochemical Factorsin COVID-19 Patients? A double-Blind Clinical Trials

Author(s):
Arezoo Moini JazaniArezoo Moini JazaniArezoo Moini Jazani ORCID1, Shahram HabibzadehShahram Habibzadeh2, Hamidreza Nasimi Doost AzgomiHamidreza Nasimi Doost Azgomi1, 3, Alireza Nasimi Doost AzgomiAlireza Nasimi Doost Azgomi1, 3, Moharram AghabalaiiMoharram Aghabalaii4, Ramin Nasimi Doost AzgomiRamin Nasimi Doost AzgomiRamin Nasimi Doost Azgomi ORCID1, 5,*
1Traditional Medicine and Hydrotherapy Research Center, Ardabil University Of Medical Sciences, Ardabil, Iran
2Department of Infectious Disease and Tropical Medicine, Ardabil University of Medical Science, Ardabil, Iran
3School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
4Department of Infectious Disease and Tropical Medicine, Imam Khomeini Hospital, Ardabil University of Medical Sciences, Ardabil, Iran
5Pharmaceutical Sciences Research Center, Ardabil University of Medical Sciences, Ardabil, Iran

Journal of Reports in Pharmaceutical Sciences:Vol. 11, issue 2; 204-11
Published online:Dec 23, 2022
Article type:Research Article
Received:Jan 04, 2022
Accepted:Jun 06, 2022
How to Cite:Moini Jazani A, Habibzadeh S, Nasimi Doost Azgomi H, Nasimi Doost Azgomi A, Aghabalaii M, et al. Dose Kelofan Syrup Effective for Clinical Symptoms and Biochemical Factorsin COVID-19 Patients? A double-Blind Clinical Trials. J Rep Pharm Sci. 2022;11(2):e146245. doi: https://doi.org/10.4103/jrptps.JRPTPS_3_22

Abstract

Similar Articles

28
Aug
2023
Zahedan J Res Med Sci

Investigating the Efficacy of an Herbal Medicine Package (Anti-Flu Pulmo-Health) Along with Common Medications in Alleviating COVID-19 Symptoms in Outpatients: A Double-Blinded Randomized Controlled Trial

Reza Hasanzadeh,
Ahmad Reza Sharifi Olounabadi,
Mohsen Farrokhpour,
Khodakaram Aghaei,
Mohammad Gholami Fesharaki,
Mahboobeh Zarrabi
,et al.

Hasanzadeh R, Sharifi Olounabadi AR, Farrokhpour M, Aghaei K, Gholami Fesharaki M, et al. Investigating the Efficacy of an Herbal Medicine Package (Anti-Flu Pulmo-Health) Along with Common Medications in Alleviating COVID-19 Symptoms in Outpatients: A Double-Blinded Randomized Controlled Trial. Zahedan J Res Med Sci. 2023;25(4):e131816. doi: https://doi.org/10.5812/zjrms-131816

15
Apr
2023
Ann Mil Health Sci Res

Effect of Kefir Produced from Cow Milk on Clinical Outcomes and Immune Response of Patients with COVID-19: A Randomized Clinical Trial

Ramin Gooruee,
Naseh Pahlavani,
Vahid Hadi,
Saeid Hadi

Gooruee R, Pahlavani N, Hadi V, Hadi S. Effect of Kefir Produced from Cow Milk on Clinical Outcomes and Immune Response of Patients with COVID-19: A Randomized Clinical Trial. Ann Mil Health Sci Res. 2022;20(4):e134712. doi: https://doi.org/10.5812/amh-134712

24
Oct
2020
Archives of Clinical Infectious Diseases

Evaluation of the Efficacy of Arbidol in Comparison with the Standard Treatment Regimen of Hospitalized Patients with Covid-19: A Randomized Clinical Trial

Davood Yadegarinia,
Shabnam Tehrani,
Sara Abolghasemi,
Afshin Zarghi,
Shahnaz Sali,
Farnaz Zolfaghari

Yadegarinia D, Tehrani S, Abolghasemi S, Zarghi A, Sali S, et al. Evaluation of the Efficacy of Arbidol in Comparison with the Standard Treatment Regimen of Hospitalized Patients with Covid-19: A Randomized Clinical Trial. Arch Clin Infect Dis. 2020;15(5):e106622. doi: https://doi.org/10.5812/archcid.106622

23
Aug
2023
J Compr Ped

Efficacy of Vitamin D as Adjuvant Therapy for Treatment of Hospitalized Children with COVID-19: A Randomized Clinical Trial

Houman Hashemian,
Rasool Poorjamal,
Majid Asgharzadeh,
Saeid Sadatmansouri,
Maryam Shahrokhi

Hashemian H, Poorjamal R, Asgharzadeh M, Sadatmansouri S, Shahrokhi M. Efficacy of Vitamin D as Adjuvant Therapy for Treatment of Hospitalized Children with COVID-19: A Randomized Clinical Trial. J Compr Ped. 2023;14(4):e138083. doi: https://doi.org/10.5812/jcp-138083

17
Dec
2021

Clinical Effectiveness and Safety of Sofosbuvir–Velpatasvir as Add-on Treatment for COVID-19 Patients: Study Protocol and Preliminary Data for the Randomized Controlled Trial

Babak Sayad,
Masomeh Mehrabi,
Reza Khodarahmi,
Farid Najafi,
Ronak Miladi,
Zeinab Mohseni Afshar
,et al.

Sayad B, Mehrabi M, Khodarahmi R, Najafi F, Miladi R, et al. Clinical Effectiveness and Safety of Sofosbuvir–Velpatasvir as Add-on Treatment for COVID-19 Patients: Study Protocol and Preliminary Data for the Randomized Controlled Trial. J Rep Pharm Sci. 2021;10(2):e146970. doi: https://doi.org/10.4103/jrptps.JRPTPS_46_21


Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles